The main tasks of the Strategy for development of the pharmaceutical industry of the Russian Federation for the period up to 2030 (Pharma 2030) include increasing exports of pharmaceutical products. According to forecasts by the Russian Ministry of Industry and Trade, by 2030, exports of Russia-made pharma products could demonstrate a five-fold growth if state support measures are implemented. Which support measures are needed to reach the set goal? What is hampering exports of Russian medicines? How can the state support the domestic producer? What else do Russian manufacturers need to grow their export potential?
– Barriers to export of Russian pharmaceuticals
– Differences in other countries’ regulatory requirements for registering medicines and launching their sale on the consumer market
– Range of medicines and priority sales markets for Russian medicines
– Administrative and/or financial support measures by the state
– Prospects for alliances of domestic producers with international pharma companies for joint promotion on overseas markets.
Anna Guseva, Head of Transaction Advisory Services for Companies in Medical and Biological Industry in the CIS, EY
Ivan Glushkov, Deputy General Director, STADA CIS
Zakhar Golant, Chairman of the Board, Union of Pharmaceutical and Biomedical Clusters of Russia; Head of Healthcare Committee
Vasily Ignatiev, General Director, R-Pharm
Oksana Monge, General Director, Sanofi Russia
Alexey Torgov, Director of the Department for Work with Governmental Authorities, Deputy Director General, BIOKAD
Dmitry Khalilov, Partner, Life Sciences & Health Leader, Central, Eastern and Southeastern Europe & Central Asia, EY
Vladimir Khristenko, President, Nanolek
Sergey Tsyb, First Deputy Minister of Industry and Trade of the Russian Federation
Dmitriy Chagin, Chairman of the Board of the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union
The modern industrial policy of a metropolis consists of a broad concept that goes beyond the strategy of improving the competitiveness of individual companies and sectors.
The government views creation and support of specialized industrial infrastructure in a metropolis as the main catalyst of a city, which enables enterprises and people to acquire new opportunities to accelerate growth and socioeconomic development. In addition to expanding the capabilities of the innovative technological ecosystem through a number of targeted strategic initiatives and a standard set of benefits, special economic zones and technology parks need to take into account the importance of such factors as the availability of the required engineering infrastructure, a potential sales market, raw materials, labour resources and logistics. How do you create the largest research base in a city and transform the results of innovative research into advanced market products and solutions? How do you ensure success in commercializing the innovations of partner companies and developing their markets locally and internationally? What measures should be taken to attract high-level specialists and provide a comfortable environment to work and live in?
– Industrial growth strategy. Enhancing competitiveness and promoting innovation through industrial policy
– Sustainable urban development and economic performance. Are benefits a form of lost profit or tax revenue from investments attracted in the future?
– Industry specialization and manufacturing formats in metropolises
– The role of industrial infrastructure in solving social problems
– Infrastructure solutions and the legal framework. What can help ensure the inflow of investors and capital?
– Business expectations and demand. What requirements do residents have?
– Development of urban industrial sites and special economic zones. Global trends
Olga Arkhangelskaya, Group Leader Providing Services to Companies in Real Estate, Transport, Infrastructure, and State-Owned Companies in the CIS, EY; Chair of the Urban Land Institute (ULI) in Russia; Certified Specialist of the US Institute for Commercial Real Estate Investment (CCIM); Head of the Working Group on Financing and Investment for the Real Estate Committee of the Association of European Businesses
Alexandra Glazkova, Vice President, HR and Corporate Marketing, BIOCAD
Igor Ishchenko, Chief Executive Officer, Technopolis Moscow Special Economic Zone
Zeynep Nil Sonmez, Regional Director, Gebze Organized Industrial Zone
Alexander Prokhorov, Head of the Moscow City Department of Investment and Industrial Policy
Valentin Romanov, Executive Director, SUN Group
WU PENG, Deputy General Manger Overseas